* Evolus Inc EOLS.OQ reported a quarterly adjusted loss
of 12
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -14
cents. The mean expectation of eight analysts for the quarter
was for a loss of 7 cents per share. Wall Street expected
results to range from -9 cents to -5 cents per share.
* Revenue rose 39.8% to $61.00 million from a year ago;
analysts
expected $60.06 million.
* Evolus Inc's reported EPS for the quarter was a loss of 21
cents.
* The company reported a quarterly loss of $11.83 million.
* Evolus Inc shares had risen by 34.0% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 27.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Evolus Inc
is
$22.00
This summary was machine generated from LSEG data March 8 at
12:13 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.07 -0.12 Missed
Sep. 30 2023 -0.17 -0.16 Beat
Jun. 30 2023 -0.19 -0.19 Met
Mar. 31 2023 -0.15 -0.15 Met